A5032358026- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
- Mobile Health and mHealth Applications
- Autism Spectrum Disorder Research
- Autoimmune Neurological Disorders and Treatments
- Neurobiology of Language and Bilingualism
- Cerebrovascular and Carotid Artery Diseases
- Health Literacy and Information Accessibility
- Lysosomal Storage Disorders Research
- Blood properties and coagulation
- Botulinum Toxin and Related Neurological Disorders
- Telemedicine and Telehealth Implementation
- Gambling Behavior and Treatments
- Artificial Intelligence in Healthcare
- Neurological and metabolic disorders
- Marriage and Sexual Relationships
- Stroke Rehabilitation and Recovery
- Acute Ischemic Stroke Management
- Sexuality, Behavior, and Technology
- Chronic Disease Management Strategies
- Infectious Encephalopathies and Encephalitis
- Neurological Disorders and Treatments
University of Uyo Teaching Hospital
2013-2025
Clinical disease registries are useful for quality improvement in care, benchmarking standards, and facilitating research. Collaborative networks established thence can enhance national international studies by generating more robust samples credible data promote knowledge sharing capacity building. This report describes the methodology, baseline data, prospects of Nigeria Parkinson Disease Registry.This registry was November 2016. Ethics approval obtained all sites. Basic anonymized...
Data on non-motor symptoms (NMS) in black Africans with Parkinson's disease (PD) are sparse.To describe the profile of NMS Nigeria PD Registry (NPDR) cohort and explore relationship between motor phenotype.We conducted a cross-sectional study frequency burden NMS, based scale (NMSS) Chaudhuri method respectively our cohort. Baseline demographics, characteristics (Hoehn Yahr stage, MDS-UPDRS total score Part III score), phenotype (based Stebbin et al's algorithm), levodopa equivalent daily...
Trial designThis was a single-blind randomized controlled trial that compared motor recovery between 2 groups of stroke patients: those on fluoxetine 20mg daily + standard therapy; and the control group who received therapy only.Sixty participants were enrolled in 1:1 ratio function assessed using FMMS, Barthel index modified Rankin score.
Background: Stroke is one of the leading causes morbidity and mortality globally. In recent time, there increasing evidence that suggest increased plasma fibrinogen associated with risk stroke unfavourable clinical outcome.
 Objectives: To determine levels in patients compare healthy controls.
 Study Design: The study design was Prospective case- control study. 
 Place Duration Study: conducted department Internal Medicine (Neurology Unit) Haematology between March to August,...